Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Plus, Why We Should Still Be Thinking About Cumulative Population Immunity

Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Considerations for Consumers, Providers, and Payers

The concept of “healthcare delivery” is dramatically shifting and opportunities for stakeholders abound.

VP of Client Delivery, Quil

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Why Organizational Structures Will Experience an Overhaul

Flexible staffing models, broad leadership skill sets, non-traditional collaboration, and more will help organizations thrive post-pandemic.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Insights in your inbox

Subscribe

Livongo and Singularity University Predict What May Scale Next

Technology presents an opportunity to redefine a care delivery model that's more continuous, more personalized, and more human.

The center of care delivery is shifting from physician offices to new digital and home hubs, and healthcare's future has great potential.

Co-Founder & CEO, Omada Health
Co-Founder and CEO, Physera
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

An Analysis of Infection Odds Based on US County

Our new model projects the chance that within a gathering of random people, there's an active COVID-19 infection.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

How stakeholders can find sustainable wellness options for seniors struggling with emotional and physical isolation.

CEO, SecureSeniorConnections™
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Senior Knowledge Expert, Oliver Wyman

Timeline to Normalcy - Updated March 15, 2021

Our revised analysis and state-by-state outlook suggest the US may achieve pHIT in early summer if vaccinations align with a more optimistic scenario.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe